Biomarkers Europe 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences
Merck Healthcare at Biomarkers Europe 2026
Oct 13–14, 2026 Basel, Switzerland ~1k attendees Website
Merck Healthcare takes part in 6 sessions at Biomarkers Europe 2026 in Basel. Its sessions cover the rules for pairing drugs with companion diagnostics in the US and EU, and multiplex tissue staining in early drug development. One screens tumour antigens by imaging many fluorescent markers in tissue, and another asks how AI that designs biology could shape personalised medicine.
| Organization | Biomarkers Europe 2026 Attendance |
|---|---|
Merck Healthcare Darmstadt, Germany | |
Healthcare business of Merck KGaA, Darmstadt, developing and marketing medicines in oncology, neurology, immunology and fertility. | Talk Tue Oct 13 11:50am–12:15pm Precision Medicine: Drug/CDx Regulatory Strategy In The US And EU Clinical & companion diagnostic development Panel Tue Oct 13 12:40pm–1:30pm IVDR Regulations & Their Impact Clinical & companion diagnostic development Talk Tue Oct 13 2:30pm–2:55pm Profiling Tumor-Associated Antigens - A Screening Approach Using Spatial Highplex IF Digital pathology & spatial biomarkers Talk Tue Oct 13 2:55pm–3:20pm To Multiplex Or Not To Multiplex- The Question In Preclinical Drug Development Biomarker discovery & translation Talk Wed Oct 14 8:40am–9:10am From Data To Design: AI-Driven Generative Biology And The Future Of Personalized Medicine Multimodal & AI-enabled precision medicine Panel Wed Oct 14 3:15pm–4:05pm AI-Enabled Clinical Trial Innovation - From Biomarker Data To Decision Multimodal & AI-enabled precision medicine |
Instantly find 20 buyers from Merck Healthcare
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Biomarkers, CDx & Precision Medicine or its organizers. Submit a correction